Your Questions Answered: Emerging Trends in Pharma Funding and M&A

Capital continues to flow toward clinical-stage and platform biotech companies, with a wave of new deals, partnerships, and public offerings reshaping the competitive landscape across oncology, rare disease, and AI-driven drug discovery. Here is a guide to the most significant activity of the past week.